OTC COVID-19 Test Gets FDA Emergency Use Authorization

The Detect test is meant to work in unison with a proprietary app that gives users instructions on how to perform the test and interpret their results. Detect is also developing an electronic travel pass system with an add-on telehealth service so that their test may be used for travel and event entry. As a vote of confidence, Detect received an $8.1 million contract to increase manufacturing from the NIH Rapid Acceleration of Diagnostics Initiative.